Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-22-005599

Options or other derivatives

  • Interim CEO & General Counsel acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Vogt Frederick G Interim CEO & General Counsel 2022-01-14 Grant or award · Restricted Stock Units +250,000 250,000 D
Loading xslF345X03/tm223806-4_4seq1.xml…